Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

316
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
316
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

710
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
710
Drug Therapy01:28

Drug Therapy

92
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
92
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

537
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
537
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

312
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
312
Neurotransmitters01:31

Neurotransmitters

1.3K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal changes in Mediterranean-style diet adherence and ultra-processed food exposure in relation to psychological distress at follow-up: A 12-year analysis of the Melbourne collaborative cohort study.

Journal of affective disorders·2026
Same author

Multidisciplinary research priorities for artificial intelligence in mental health: a call to action.

The lancet. Psychiatry·2026
Same author

Meal Timing Jetlag is associated with anxiety, depressive and insomnia symptoms in a French-speaking online cohort: A cross-sectional analysis of ALIMENTAL 2.

Journal of affective disorders·2026
Same author

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same author

Dietary Inflammatory Index and Cardiovascular Disease Risk in Australian Adults: A Secondary Analysis of the OLIVAUS Trial.

Nutrients·2026
Same author

Investigating Dietary Polyphenol Intake in the Australian Population: Results From the 2011-12 National Nutrition and Physical Activity Survey.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2026

Related Experiment Video

Updated: Aug 30, 2025

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.0K

Nutraceuticals in mood disorders: current knowledge and future directions.

Nikolaj Travica1, Scott Teasdale2,3, Wolfgang Marx1

  • 1IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Food & Mood Centre, School of Medicine, Barwon Health, Deakin University, Geelong.

Current Opinion in Psychiatry
|August 31, 2022
PubMed
Summary
This summary is machine-generated.

Nutraceuticals show promise for depression as adjunctive or monotherapy, but evidence for bipolar disorder is limited. More research is needed on their long-term safety and efficacy in mood disorders.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

169
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

580

Related Experiment Videos

Last Updated: Aug 30, 2025

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.0K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

169
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

580

Area of Science:

  • Nutritional Psychiatry
  • Psychopharmacology
  • Evidence-Based Medicine

Background:

  • Mood disorders, including depression and bipolar disorder, represent a significant global health challenge.
  • Nutraceuticals are increasingly explored for their potential therapeutic benefits in mental health.
  • A comprehensive understanding of their efficacy and safety is crucial for clinical application.

Approach:

  • Systematic review of clinical trial evidence on nutraceuticals for mood disorders.
  • Analysis of specific agents like omega-3, probiotics, zinc, saffron, curcumin, and St. John's wort.
  • Evaluation of safety profiles and identification of research gaps.

Key Points:

  • Omega-3, probiotics, zinc, saffron, and curcumin are recommended as adjunctive treatments for depression.
  • St. John's wort is recommended as a monotherapy for depression.
  • Evidence for nutraceutical efficacy in bipolar disorder is limited, with omega-3 showing weak adjunctive recommendations.
  • The overall safety profile of most nutraceuticals is acceptable, but long-term data is needed.

Conclusions:

  • Several nutraceuticals demonstrate efficacy as adjunctive or monotherapy for depression.
  • Further high-quality randomized controlled trials are required to establish the role of nutraceuticals in bipolar disorder.
  • Future research should explore novel mechanisms, combinations, and predictors of treatment response for personalized clinical use.